SEC Form D filing
Duracrin, LLC, 2026-02-25
An SEC Form D private-offering notice from New Haven, CT, a $1,000,000 filer-stated offering target in Biotech. Filed 2026-02-25. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Duracrin, LLC Verified via SEC Form D
Filed 2026-02-25Filed to raise $1,000,000First money in 2026-02-03Raised so far $1,000,000HQ (as filed) New Haven, CTSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Named in the filing 2 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Allyx Therapeutics, Inc., 2026-03-03, $4M, New Haven, CT
- Onyx Bio, Inc., 2026-02-26, $8M, Berkeley, CA
- Convexity Scientific Inc., 2026-03-02, $2.9M, New Haven, CT
- GeneCapture, Inc., 2026-02-26, $3M, Huntsville, AL
- Quarry Heme, Inc, 2026-02-25, $13.5M, New Haven, CT
- Quarry DAC, Inc, 2026-02-25, $2.1M, New Haven, CT
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.